To assuage some of that concern, the agency released a guidance that outlines conditions for approving a Covid-19 vaccine.

Gilead Sciences, in a self-described effort to do “the right and responsible thing,” may have just set a precedent its industry peers will come to resent.

Sanofi is considering cutting hundreds of jobs and will discuss potential steps with staff representatives over the coming days.

The European Commission is in advanced talks with Johnson & Johnson to reserve or buy up-front doses of its Covid-19 vaccine under development.

The U.S. Chamber of Commerce has suggested that more transparency is needed surrounding the Covid-19 vaccine deals that are being struck between drug makers and governments.

AstraZeneca found partners to manufacture and distribute 2 billion doses of an experimental Covid-19 vaccine created by Oxford University.

The Trump administration mishandled the initial distribution of remedesivir, the experimental Gilead Sciences Covid-19 medicine, delaying treatment to some critically ill patients.

A group of academics and pharmacists argue that assigning scores based on a mix of regulatory actions and chemical analysis would motivate drug makers to produce more “quality” drugs.

STAT spoke with Phlow CEO Eric Edwards about the criticism over his track record, Phlow's plan to create a national drug ingredient stockpile, and the huge government contract the company…

#Covid19 vaccines in development may be more like those that protect against influenza — reducing the risk of contracting the disease and of experiencing severe symptoms should infection occur.

The Trump administration signed a contract with Phlow, a new company in Richmond, Va., to make generic drugs and pharmaceutical ingredients needed to treat Covid-19.

Under an “America First” president, public health experts worry the U.S. could seek to gobble up early supplies of Covid-19 vaccine.

Sanofi insisted it would make its Covid-19 vaccine available in all countries, hours after chief executive Paul Hudson said the U.S. will get first access.

After doubts arose about whether hydroxychloroquine is safe and effective for treating Covid-19, states are donating supplies to patients who need them to treat other illnesses or seeking refunds.

Gilead faces the challenge of scaling up production of remdesivir, its experimental #Covid19 drug that the whole world may want.

The Trump administration is organizing a Manhattan Project-style effort to drastically cut the time needed to develop a #coronavirus vaccine.

The Japanese prime minister said Japan is on the verge of initiating a fast-track approval process for remdesivir, the experimental Gilead Sciences antiviral being tested against the #coronavirus.

Thousands of Covid-19 patients worldwide are signing up for studies exploring whether antimalaria drugs fight off infections of the novel coronavirus.

The U.S. government is pledging up to $483 million to accelerate the development of a Moderna experimental Covid-19 vaccine.

Brazil has become the latest country in which some lawmakers are seeking to issue compulsory licenses for medicines and vaccines to combat the novel coronavirus.

Creating a consensus on testing and certification, driven by employers willing and able to take early action, will accelerate America's return to work. No employer in America can afford to…

Not enforcing the Food and Drug Administration Amendments Act puts Americans at greater risk of wasting money on useless medical products and being injured by unsafe ones.

Americans admire health care workers, and that admiration has justifiably grown during this crisis. But we should realize that the professionalism underneath their work is fragile and needs to be…

“We need an army of 300,000 people” to find the contacts of people infected with the #coronavirus, said former CDC director Tom Frieden.

Homeless people who have the #coronavirus, or are being checked for it, are left with only one place to be quarantined, doctors say: the hospital.

A crisis can sometimes lead to something better. We should seize the Covid-19 pandemic as an opportunity to build the robust maternity system the U.S. sorely needs.